Austrian hospitality executive with public-company operating and capital-markets experience, focused on hotel portfolio optimization, asset-light franchising and revenue-management strategies. Winfried Buchbauer combines operational leadership, investor relations and portfolio management skills to drive EBITDA margin expansion, selective asset disposal and fee-based income growth. Known for executing turnaround initiatives, refining distribution channels and aligning corporate strategy with institutional investors and private-equity partners.
Austrian hospitality executive with public-company operating and capital-markets experience, focused on hotel portfolio optimization, asset-light franchising and revenue-management strategies. Winfried Buchbauer combines operational leadership, investor relations and portfolio management skills to drive EBITDA margin expansion, selective asset disposal and fee-based income growth. Known for executing turnaround initiatives, refining distribution channels and aligning corporate strategy with institutional investors and private-equity partners.
Operator-investor mindset focused on value creation through asset-light hospitality models, revenue-management optimization and selective portfolio pruning. Prioritizes fee-income growth and margin expansion via disciplined franchising, distribution-channel refinement and hands-on turnaround execution. Capital allocation favors reinvestment in high-ROC assets, strategic disposals of underperformers and partnerships with institutional and private-equity capital to de-risk balance-sheet exposure. Decision-making combines operational KPIs with investor-relations discipline, a medium-term horizon for EBITDA improvement, and a conservative risk framework centered on cashflow predictability and scalable, fee-based growth.
Operator-investor mindset focused on value creation through asset-light hospitality models, revenue-management optimization and selective portfolio pruning. Prioritizes fee-income growth and margin expansion via disciplined franchising, distribution-channel refinement and hands-on turnaround execution. Capital allocation favors reinvestment in high-ROC assets, strategic disposals of underperformers and partnerships with institutional and private-equity capital to de-risk balance-sheet exposure. Decision-making combines operational KPIs with investor-relations discipline, a medium-term horizon for EBITDA improvement, and a conservative risk framework centered on cashflow predictability and scalable, fee-based growth.
| Trades 11361 | Longs Won 7003/11361 61% | Profit Factor 3.3 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.88M |
| Average Win $1.17M | Best Trade (Sep 30) $111.19M | Sharpe Ratio -35.7 |
| Average Loss -$570,827.42 | Worst Trade (Jun 30) -$54.25M | Z-Score -0.58 (43.63%) |
| Commissions $0 | Avg. Trade Length 1y 10m | Expectancy $502,640.45 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 22,727 | 20,455 | 18,182 | 15,909 | 13,636 | 11,364 | 9,091 | 6,818 | 4,545 | 2,273 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 119,272 | $16.94M | $16.5M | - | -$431,658.26 | -2.55% | -0.245% |
AA Alcoa Corporation | 42,614 | $2.3M | $1.93M | - | -$370,152.08 | -16.1% | +0.645% |
AAON Aaon Inc. | 120,500 | $15.12M | $10.73M | - | -$4.39M | -29.04% | +1.678% |
AAPL Apple Inc. | 1.98M | $381.96M | $610.66M | - | $228.7M | 59.87% | -7.354% |
ABBV AbbVie Inc. | 267,697 | $51.43M | $67.18M | - | $15.74M | 30.61% | -2.513% |
ABCL AbCellera Biologics Inc. | 62,000 | $604,500 | $354,020 | - | -$250,480 | -41.44% | +0.351% |
ABEV Ambev S.A. | 500,000 | $1.36M | $1.55M | - | $190,000 | 13.92% | -0.321% |
ABT Abbott Laboratories | 464,852 | $59.04M | $49.13M | - | -$9.9M | -16.78% | +0.085% |
ABVX Abivax SA ADR | 110,000 | $12.16M | $13.74M | - | $1.58M | 12.98% | +0.475% |
ACAD Acadia Pharmaceuticals Inc. | 133,700 | $2.72M | $3.46M | - | $738,554.55 | 27.15% | -2.561% |
ACGL Arch Capital Group Ltd | 28,830 | $2.79M | $2.9M | - | $111,377.38 | 4% | -0.603% |
ACWI iShares MSCI ACWI ETF | 253,157 | $31.83M | $39.6M | - | $7.77M | 24.41% | +0.495% |
ADBE Adobe Inc. | 171,629 | $47.45M | $42.98M | - | -$4.47M | -9.43% | +1.013% |
ADI Analog Devices, Inc. | 61,059 | $16.76M | $22.43M | - | $5.68M | 33.88% | +0.202% |
ADM Archer-Daniels-Midland Co | 9,064 | $522,024.33 | $718,503.28 | - | $196,478.95 | 37.64% | -1.662% |
ADP Automatic Data Processing Inc. | 19,870 | $4.09M | $5.29M | - | $1.2M | 29.39% | +0.982% |
ADPT Adaptive Biotechnologies Corporation | 8,925 | $968,184 | $201,437.25 | - | -$766,746.75 | -79.19% | -6.658% |
ADSK Autodesk, Inc. | 565,616 | $149.9M | $132.47M | - | -$17.43M | -11.63% | -0.328% |
AEIS Advanced Energy Industries Inc. | 13,582 | $4.38M | $3.93M | - | -$450,786.72 | -10.28% | +5.564% |
AEM Agnico Eagle Mines Limited | 1,330 | $158,176.9 | $193,209.1 | - | $35,032.2 | 22.15% | -3.635% |